Anavex Life Sciences (AVXL) Interest Expenses (2010 - 2025)

Anavex Life Sciences (AVXL) has 16 years of Interest Expenses data on file, last reported at $2.5 billion in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses rose 3589.52% year-over-year to $2.5 billion; the trailing twelve-month figure through Dec 2025 stood at $2.5 billion (up 3589.52% YoY), and the FY2025 full-year result was $39.7 billion, up 42960.08% from the prior year.
• Interest Expenses eased to $2.5 billion in Q4 2025, from $39.7 billion in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $39.7 billion in Q3 2025 to a low of $7.5 million in Q2 2024.
• A 5-year average of $2.2 billion and a median of $60.5 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses slumped 80.88% in 2024 and jumped 42960.08% in 2025, its largest moves.
• Tracing AVXL's Interest Expenses over 5 years: stood at $132.0 million in 2021, then sank by 61.61% to $50.7 million in 2022, then fell by 5.93% to $47.7 million in 2023, then soared by 44.96% to $69.1 million in 2024, then jumped by 3589.52% to $2.5 billion in 2025.
• Business Quant data shows AVXL's Interest Expenses at $2.5 billion in Q4 2025, $39.7 billion in Q3 2025, and $45.8 million in Q2 2025.